Question
- What is the clinical effectiveness of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?
- What is the cost-effectiveness of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?
- What are the evidence-based guidelines associated with the use of difluoromethylornithine (DFMO) for the treatment or preventative treatment of neuroblastoma in the pediatric population?
Key Message
One non-randomized study was identified regarding difluoromethylornithine (DFMO) for the treatment of prevention of neuroblastoma in the pediatric population.